Cargando…

Short Term Oral Methylergonovine Maleate Prophylaxis for Status Migrainosus. Case Series and Review of Literature

Background: Intravenous dihydroergotamine (DHE) is frequently used during inpatient hospitalizations or outpatient infusion therapies for 3–5 days in order to break the continuous cycle of status migrainosus. We tried a short term 7 days prophylaxis of oral methylergonovine after discharge in order...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haque, Najiya, Tariq, Nauman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440365/ https://www.ncbi.nlm.nih.gov/pubmed/30967829 http://dx.doi.org/10.3389/fneur.2019.00201

Ejemplares similares

Myocardial ischaemia secondary to intramyometrial injection of methylergonovine maleate
por: Jain, Shruti, et al.
Publicado: (2016)

Status migrainosus inpatient treatment with eptinezumab (SMITE): study protocol for a randomised controlled trial
por: Ray, Jason Charles, et al.
Publicado: (2022)

Role of intravenous levetiracetam in status migrainosus
por: Farooq, Muhammad U., et al.
Publicado: (2007)

Tozinameran: Status migrainosus: case report
Publicado: (2022)

Status Migrainosus and Endometriosis: A Case Report and Review of the Literature
por: Frankel, Lexi R, et al.
Publicado: (2021)

Status migrainosus as an initial presentation of multiple sclerosis
por: Alroughani, Raed, et al.
Publicado: (2015)

Fatal status migrainosus in Chiari 1 malformation
por: Jokonya, Luxwell, et al.
Publicado: (2019)

Inadvertent Methylergonovine Administration to a Neonate
por: Corbett, Bryan M., et al.
Publicado: (2016)

CADASIL presenting as status migrainosus and persisting aura without infarction
por: Sacco, Simona, et al.
Publicado: (2008)

Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus
por: Mullaguri, Naresh, et al.
Publicado: (2018)

Persistent aura and status migrainosus in CADASIL syndrome: A case report
por: Hamid, Mohamed, et al.
Publicado: (2022)

Post-partum myocardial ischemia due to intramuscular methylergonovine-induced coronary vasospasm: case report
por: Jang, Sae K, et al.
Publicado: (2023)

Risk and Predisposing Factors for Suicide Attempts in Patients with Migraine and Status Migrainosus: A Nationwide Population-Based Study
por: Harnod, Tomor, et al.
Publicado: (2018)

Anaphylaxis to Chlorpheniramine Maleate and Literature Review
por: Choi, Yong Won, et al.
Publicado: (2019)

Women and stroke: disparities in clinical presentation, severity, and short- and long-term outcomes
por: Naveed, Hiba, et al.
Publicado: (2023)

Seizure prophylaxis following aneurysmal subarachnoid haemorrhage (SPSAH): study protocol for a multicentre randomised placebo-controlled trial of short-term sodium valproate prophylaxis in patients with acute subarachnoid haemorrhage
por: Chen, Yuqi, et al.
Publicado: (2022)

Brachial Artery Vasospasm From Sequential Use of Intravenous Promethazine and Dihydroergotamine for Treatment of Status Migrainosus: A Case Report
por: Johns, Christopher, et al.
Publicado: (2023)

Trimipraminium maleate
por: Jasinski, Jerry P., et al.
Publicado: (2010)

Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study
por: Niño-Maldonado, Alfredo I, et al.
Publicado: (2009)

A comparative study of methylergonovine and 15-methyl prostaglandin F(2α) in active management of third stage of labor
por: Gupta, Anshu
Publicado: (2013)

Creatininium hydrogen maleate
por: Jahubar Ali, A., et al.
Publicado: (2011)

Flunarizinium hydrogen maleate
por: Kavitha, Channappa N., et al.
Publicado: (2013)

Maleate salts of bedaquiline
por: Zeller, Matthias, et al.
Publicado: (2021)

Optimized and Validated Spectrophotometric Methods for the Determination of Enalapril Maleate in Commercial Dosage Forms
por: Rahman, Nafisur, et al.
Publicado: (2008)

Crystal structure of levomepromazine maleate
por: Gál, Gyula Tamás, et al.
Publicado: (2016)

Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine—a case report
por: Consoli, Stefano, et al.
Publicado: (2021)

The Tadpole Pupil: Case Series With Review of the Literature and New Considerations
por: Udry, Morgane, et al.
Publicado: (2019)

Stenotrophomonas maltophilia Meningitis - A Case Series and Review of the Literature
por: Khanum, Iffat, et al.
Publicado: (2020)

A Case Series and Literature Review of Vertebral Artery Stump Syndrome
por: Zhang, Wenbin, et al.
Publicado: (2022)

Recurrent Trigeminal Neuralgia: A Case Series and a Review of the Literature
por: Vardhan, Harsha, et al.
Publicado: (2022)

Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature
por: Ford, Hannah, et al.
Publicado: (2022)

Short-term and long-term outcomes in patients with cryptococcal meningitis after ventriculoperitoneal shunt placement
por: Wen, Junxian, et al.
Publicado: (2022)

Essential oil–related status epilepticus: A small case series study
por: Mathew, Thomas, et al.
Publicado: (2020)

Short-Term Central Adaptation in Benign Paroxysmal Positional Vertigo
por: Choi, Seo-Young, et al.
Publicado: (2020)

Short- and Long-Term Effects of DBS on Gait in Parkinson's Disease
por: Brozova, Hana, et al.
Publicado: (2021)

The value of immunotherapy in children with initial short-term frequent seizures
por: Zhao, Yongheng, et al.
Publicado: (2022)

Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration: Case Series and Review of Literature
por: Chatham, Mathew, et al.
Publicado: (2021)

2-Methylimidazolium hydrogen maleate
por: Liu, Zhi-Xiong
Publicado: (2009)

2-Carboxypyridinium maleate
por: Pandi, P., et al.
Publicado: (2012)

The Outcome of Status Epilepticus and Long-Term Follow-Up
por: Horváth, László, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jj6unlej3ptftldfe1c7m1d2j3